Introduction. Anticoagulants have the key role in prevention of thromboembolism including ischemic stroke, in patients with non-valvular atrial fibrillation (NVAF). The European Association of Cardiology (ESC) recommends new oral anticoagulant drugs (NOACs) as first choice therapy because of approved effectiveness and safety profile compared to vit...

By Nevena Todorović, Nataša Pilipović-Broćeta, Aleksandra Lukić, Brankica Marković, Verica Prodanović